These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10813038)

  • 21. Ritonavir manufacturing problems.
    Highleyman L
    BETA; 1998 Oct; ():4. PubMed ID: 11365991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA clears HIV drug for patients with resistant virus.
    AIDS Read; 2006 Aug; 16(8):392. PubMed ID: 16933372
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral approved for use in infants.
    Am Fam Physician; 2001 Jun; 63(12):2469. PubMed ID: 11430459
    [No Abstract]   [Full Text] [Related]  

  • 25. Problem with Norvir capsules.
    Posit Aware; 1998; 9(5):16. PubMed ID: 11365881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA notifications. FDA approves pediatric dosing for ritonavir.
    AIDS Alert; 2005 Nov; 20(11):129-30. PubMed ID: 16365934
    [No Abstract]   [Full Text] [Related]  

  • 27. Two more HIV protease inhibitors approved.
    Fox JL
    Nat Biotechnol; 1996 Apr; 14(4):427. PubMed ID: 9669874
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA notifications. HIV-1 adult treatment guidelines are updated.
    AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795141
    [No Abstract]   [Full Text] [Related]  

  • 29. Indinavir (Crixivan): new packaging and strength.
    Res Initiat Treat Action; 1999 Apr; 5(2):33. PubMed ID: 11366284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA clearance for ritonavir in children with AIDS.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
    [No Abstract]   [Full Text] [Related]  

  • 31. Norvir capsules - manufacturing problem.
    Crit Path AIDS Proj; 1998; (No 33):31. PubMed ID: 11366366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaletra (ABT-378/r) approved.
    James JS
    AIDS Treat News; 2000 Sep; (351):2-3. PubMed ID: 12173550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amprenavir approved.
    AIDS Patient Care STDS; 1999 Jul; 13(7):438. PubMed ID: 10870601
    [No Abstract]   [Full Text] [Related]  

  • 34. Ritonavir (Norvir).
    Res Initiat Treat Action; 2000 Mar; 6(1):26-7. PubMed ID: 11708183
    [No Abstract]   [Full Text] [Related]  

  • 35. The Norvir switch.
    Schoofs M
    J Int Assoc Physicians AIDS Care; 1998 Sep; 4(9):64-8. PubMed ID: 11365801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA notifications. Alternative dosing regimen for atazanavir is approved.
    AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
    [No Abstract]   [Full Text] [Related]  

  • 37. Ritonavir alert.
    Proj Inf Perspect; 1998 Sep; (25):12. PubMed ID: 11365839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
    Ananworanich J; Siangphoe U; Mahanontharit A; Hill A; Hirschel B; Ruxrungtham K
    Antivir Ther; 2004 Dec; 9(6):1035-6. PubMed ID: 15651763
    [No Abstract]   [Full Text] [Related]  

  • 39. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 40. Kaletra lower-strength pediatric tablet approved in Europe.
    AIDS Patient Care STDS; 2008 May; 22(5):437-8. PubMed ID: 18521973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.